DVL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.851200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.749000E-01
Normal-vs-Stage2
5.229800E-01
Normal-vs-Stage3
2.783800E-02
Normal-vs-Stage4
5.555400E-01
Stage1-vs-Stage2
5.916000E-01
Stage1-vs-Stage3
2.757200E-01
Stage1-vs-Stage4
7.283000E-01
Stage2-vs-Stage3
2.096600E-01
Stage2-vs-Stage4
8.953200E-01
Stage3-vs-Stage4
1.933420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.235200E-01
Normal-vs-AfricanAmerican
6.755600E-02
Normal-vs-Asian
1.492440E-01
Caucasian-vs-AfricanAmerican
3.781600E-01
Caucasian-vs-Asian
2.978200E-01
AfricanAmerican-vs-Asian
8.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.601600E-01
Normal-vs-Female
6.832200E-01
Male-vs-Female
7.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.492200E-01
Normal-vs-Age(41-60Yrs)
9.049000E-01
Normal-vs-Age(61-80Yrs)
2.330200E-01
Normal-vs-Age(81-100Yrs)
1.919410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.637400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.344000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.449600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.297900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.330300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.185200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.064600E-01
Normal-vs-Daily Drinker
5.194400E-01
Normal-vs-Weekly Drinker
7.927200E-01
Normal-vs-Occasional Drinker
6.282600E-01
Normal-vs-Social Drinker
6.206000E-01
Non Drinker-vs-Daily Drinker
9.345800E-01
Non Drinker-vs-Weekly Drinker
5.291800E-01
Non Drinker-vs-Occasional Drinker
6.790800E-01
Non Drinker-vs-Social Drinker
5.993200E-01
Daily Drinker-vs-Weekly Drinker
4.152000E-01
Daily Drinker-vs-Occasional Drinker
5.832600E-01
Daily Drinker-vs-Social Drinker
5.209000E-01
Weekly Drinker-vs-Occasional Drinker
6.854400E-01
Weekly Drinker-vs-Social Drinker
7.600400E-01
Occasional Drinker-vs-Social Drinker
9.031600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.135400E-01
Normal-vs-Grade 2
7.498600E-01
Normal-vs-Grade 3
7.866800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.100600E-01
Grade 1-vs-Grade 3
6.396000E-01
Grade 1-vs-Grade 4
8.135400E-01
Grade 2-vs-Grade 3
2.729400E-01
Grade 2-vs-Grade 4
7.498600E-01
Grade 3-vs-Grade 4
7.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.198400E-01
Normal-vs-NonDiabetic
7.145000E-01
Diabetic-vs-NonDiabetic
1.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.376400E-01
Normal-vs-NoPancreatitis
6.102800E-01
Pancreatitis-vs-NoPancreatitis
8.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.629000E-01
Normal-vs-N1
5.679200E-01
N0-vs-N1
9.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.101600E-01
Normal-vs-TP53-NonMutant
3.802400E-01
TP53-Mutant-vs-TP53-NonMutant
1.548030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
